Creekmur Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-500
Closed -$21.8K 780
2024
Q4
$21.8K Sell
500
-2,500
-83% -$460K 0.01% 325
2024
Q3
$183K Sell
3,000
-100
-3% -$18.7K 0.04% 123
2024
Q2
$111K Buy
+3,100
New +$514K 0.03% 165

Other funds holding ABBV

Creekmur Asset Management's ABBV Position: Q3 2025 in Review

Creekmur Asset Management increased its AbbVie (ABBV) stake by 18% in Q3 2025, buying an estimated $587K and bringing the position to 18,963 shares worth $4.39M. The position accounts for 0.73% of the portfolio, ranked #24.

Creekmur Asset Management first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Creekmur Asset Management held 18,963 shares of AbbVie worth $4.39M as of Q3 2025.
  • Creekmur Asset Management bought 2,884 AbbVie shares in Q3 2025, an estimated $587K.
  • AbbVie made up 0.73% of Creekmur Asset Management's portfolio in Q3 2025, its #24 holding.
  • Creekmur Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.